Effect of magnesium sulfate on oxygenation and lung mechanics in morbidly obese patients undergoing bariatric surgery: a prospective double-blind randomized clinical trial

Background: Respiratory mechanics are often significantly altered in morbidly obese patients and magnesium sulfate (MgSO4) is a promising agent for managing several respiratory disorders. This study aimed to examine the effects of MgSO4 infusions on arterial oxygenation and lung mechanics in patients with morbid obesity undergoing laparoscopic bariatric surgery. Methods: Forty patients with morbid obesity aged 21-60 years scheduled for laparoscopic bariatric surgery under general anesthesia were randomly allocated to either the control (normal saline infusion) or MgSO4 group (30 mg/kg lean body weight [LBW] of 10% MgSO4 in 100 ml normal saline intravenously over 30 min as a loading dose, followed by 10 mg/kg LBW/h for 90 min). The primary outcome was intraoperative arterial oxygenation (Delta PaO2/FiO(2)). Secondary outcomes included intraoperative static and dynamic compliance, dead space, and hemodynamic parameters. Results: At 90 min intraoperatively, the Delta PaO2/FiO(2) ratio and the. dynamic lung compliance were statistically significantly higher in the MgSO4 group (mean +/- SE: 16.1 +/- 1.0, 95% CI [14.1, 18.1] and 8.4 +/- 0.5 ml/cmH(2)O, 95% CI [7.4, 9.4]), respectively), and the Delta dead space (%) was statistically significantly lower in the MgSO4 group (mean +/- SE: -8.0 +/- 0.3%, 95% CI [-8.6, -7.4], P < 0.001). No significant differences in static compliance were observed. Conclusions: Although MgSO4 significantly preserved arterial oxygenation and maintained dynamic lung compliance and dead space in patients with morbid obesity, the clinical relevance is minimal. This study failed to adequately reflect the clinical importance of these results.